Studies Addressing Rare Neurodegenerative Diseases Including ALS
Key Information
Due Date: Not Specified
Agency: United States Department of Health and Human Services
Source: Federal
Website: View Website
Funding Categories:
Funding Amount: Not Specified
Funding Type: Grant
Match Required: No
Status: Forecasted
Contact Info:
terrin.brown@fda.hhs.gov
Terrin Brown Grantor 2404027610
Terrin Brown Grantor 2404027610
Overview
The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development of interventions intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children. Through the support of these studies, FDA expects to address critical knowledge gaps, exert a significant impact on rare neurodegenerative diseases, and to inform current or future product development.
Show More
Additional Info
Posted Date: August 14, 2024
Application Due Date: Not Specified
Estimated Award Date: Not Specified
Eligible Applicants:
- Unrestricted
- State governments
- Independent school districts
- Private institutions of higher education
- City or township governments
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Public housing authorities/Indian housing authorities
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Native American tribal organizations (other than Federally recognized tribal governments)
- Public and State controlled institutions of higher education
- County governments
- Small businesses
- Special district governments
- For profit organizations other than small businesses
- Native American tribal governments (Federally recognized)
Apply with Confidence
Our partners at Syncurrent help local governments move from searching to applying. Confirm eligibility, access funding documents, and begin building a complete application in a single secure platform.
